Updated Jul. 13, 2012 at 5:05 p.m.
GSK
Research Triangle Park, N.C. — Glaxo applies for approval of drug to treat chronic obstructive pulmonary disease in the U.S. and Europe and for treatment of asthma in the EU....
GSK seeks OK for new respiratory disease drug
Post a comment
Print this blog postE-mail blog post
Share
GSK
Research Triangle Park, N.C. — Glaxo applies for approval of drug to treat chronic obstructive pulmonary disease in the U.S. and Europe and for treatment of asthma in the EU....
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 WRAL Tech Wire. All rights reserved.Please log in to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
NC Biotech Center braces for worst as Senate slashes budget, too- ArchiveSocial, a new Durham success story, brings home international award
- Durham's high-tech infrastructure, talent lure Virginia company
- Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
- Raleigh-based PRA International eyes public offering
- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows